Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Thermo Fisher Scientific (TMO)

Thermo Fisher Q3 revenue rises 9% to $12.14 billion; adjusted EPS up 15% to $6.68

Positive Impact 3 of 5 earnings

Thermo Fisher reported third-quarter 2026 results for the period ended September 26, 2026, with revenue up 9% to $12.14 billion and GAAP diluted EPS up 9% to $4.64. Organic revenue growth was 6%, and the company said it would give updated 2026 guidance on its earnings call that morning, so shareholders will get the outlook only through that call and not in this filing.

Key points

  • Revenue $12.14 billion, up from $11.12 billion a year earlier; organic growth 6%
  • GAAP diluted EPS $4.64 (up 9%); adjusted EPS $6.68 (up 15% from $5.79)
  • GAAP operating margin 18.6% vs. 17.4%; adjusted operating margin 24.5% vs. 23.3%
  • Updated 2026 guidance to be provided on the October 21, 2026 call at 7:00 a.m. Eastern Time

The filing

CompanyThermo Fisher Scientific (TMO)
Form8-K, current report
Filed with the SECOct 21, 2026, 6:03 AM ET
Accession number0000097745-26-000173

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 7, 2026, 11:17 PM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.